SI-BONE, INC. Cost of Revenue
SI-BONE, INC. (SIBN) reported Cost of Revenue of $11.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-04
- SI-BONE, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $11.46M, a 16.69% increase year-over-year.
- SI-BONE, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $10.64M, a 10.93% increase year-over-year.
- SI-BONE, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $11.82M, a 15.58% increase year-over-year.
- SI-BONE, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $9.81M, a 16.27% increase year-over-year.
- SI-BONE, INC. cost of goods and services sold for fiscal 2025 was $41.05M, a 17.08% increase from fiscal 2024.
- SI-BONE, INC. cost of goods and services sold for fiscal 2024 was $35.06M, a 18.97% increase from fiscal 2023.
- SI-BONE, INC. cost of goods and services sold for fiscal 2023 was $29.47M, a 87.62% increase from fiscal 2022.
- SI-BONE, INC. cost of goods and services sold for fiscal 2022 was $15.71M, a 50.60% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.46M 10-Q · filed 2026-08-04 | $22.11M 10-Q · filed 2026-08-04 | $33.92M derived: sum of 3 quarters · filed 2026-08-04 | $43.73M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $10.64M 10-Q · filed 2026-05-11 | $22.46M derived: sum of 2 quarters · filed 2026-05-11 | $32.27M derived: sum of 3 quarters · filed 2026-05-11 | $42.09M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $11.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $21.63M derived: sum of 2 quarters · filed 2026-02-24 | $31.45M derived: sum of 3 quarters · filed 2026-08-04 | $41.05M 10-K · filed 2026-02-24 |
| 2025-09-30 | $9.81M 10-Q · filed 2025-11-10 | $19.63M derived: sum of 2 quarters · filed 2026-08-04 | $29.23M 10-Q · filed 2025-11-10 | $39.45M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $9.82M 10-Q · filed 2026-08-04 | $19.42M 10-Q · filed 2026-08-04 | $29.64M derived: sum of 3 quarters · filed 2026-08-04 | $38.08M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $9.60M 10-Q · filed 2026-05-11 | $19.82M derived: sum of 2 quarters · filed 2026-05-11 | $28.26M derived: sum of 3 quarters · filed 2026-05-11 | $36.65M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $10.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $18.66M derived: sum of 2 quarters · filed 2026-02-24 | $27.05M derived: sum of 3 quarters · filed 2026-02-24 | $35.06M 10-K · filed 2026-02-24 |
| 2024-09-30 | $8.44M 10-Q · filed 2025-11-10 | $16.83M derived: sum of 2 quarters · filed 2025-11-10 | $24.83M 10-Q · filed 2025-11-10 | $35.02M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $8.39M 10-Q · filed 2025-08-05 | $16.39M 10-Q · filed 2025-08-05 | $26.58M derived: sum of 3 quarters · filed 2026-02-24 | $33.62M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $8.00M 10-Q · filed 2025-05-06 | $18.18M derived: sum of 2 quarters · filed 2026-02-24 | $25.23M derived: sum of 3 quarters · filed 2026-02-24 | $31.54M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $10.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $17.22M derived: sum of 2 quarters · filed 2026-02-24 | $23.54M derived: sum of 3 quarters · filed 2026-02-24 | $29.47M 10-K · filed 2026-02-24 |
| 2023-09-30 | $7.04M 10-Q · filed 2024-11-12 | $13.36M derived: sum of 2 quarters · filed 2024-11-12 | $19.28M 10-Q · filed 2024-11-12 | $24.37M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $6.32M 10-Q · filed 2024-08-06 | $12.24M 10-Q · filed 2024-08-06 | $17.33M derived: sum of 3 quarters · filed 2025-02-25 | $21.50M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $5.92M 10-Q · filed 2024-05-07 | $11.01M derived: sum of 2 quarters · filed 2025-02-25 | $15.18M derived: sum of 3 quarters · filed 2025-02-25 | $18.65M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $9.26M derived: sum of 2 quarters · filed 2025-02-25 | $12.72M derived: sum of 3 quarters · filed 2025-02-25 | $15.71M 10-K · filed 2025-02-25 |
| 2022-09-30 | $4.17M 10-Q · filed 2023-11-07 | $7.63M derived: sum of 2 quarters · filed 2023-11-07 | $10.62M 10-Q · filed 2023-11-07 | $13.99M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $3.46M 10-Q · filed 2023-08-08 | $6.45M 10-Q · filed 2023-08-08 | $9.82M derived: sum of 3 quarters · filed 2023-08-08 | $12.30M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $2.98M 10-Q · filed 2023-05-02 | $6.36M derived: sum of 2 quarters · filed 2023-05-02 | $8.84M derived: sum of 3 quarters · filed 2023-05-02 | $11.21M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $5.85M derived: sum of 2 quarters · filed 2023-03-02 | $8.23M derived: sum of 3 quarters · filed 2023-03-02 | $10.43M 10-K · filed 2023-03-02 |
| 2021-09-30 | $2.48M 10-Q · filed 2022-11-08 | $4.85M derived: sum of 2 quarters · filed 2022-11-08 | $7.05M 10-Q · filed 2022-11-08 | $9.33M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $2.38M 10-Q · filed 2022-08-09 | $4.58M 10-Q · filed 2022-08-09 | $6.85M derived: sum of 3 quarters · filed 2022-08-09 | $9.43M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $2.20M 10-Q · filed 2022-05-10 | $4.47M derived: sum of 2 quarters · filed 2022-05-10 | $7.05M derived: sum of 3 quarters · filed 2022-05-10 | $9.17M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.85M derived: sum of 2 quarters · filed 2022-03-01 | $6.97M derived: sum of 3 quarters · filed 2022-03-01 | $8.90M 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.58M 10-Q · filed 2021-11-09 | $4.70M derived: sum of 2 quarters · filed 2021-11-09 | $6.63M 10-Q · filed 2021-11-09 | $8.67M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.12M 10-Q · filed 2021-08-04 | $4.05M 10-Q · filed 2021-08-04 | $6.09M derived: sum of 3 quarters · filed 2021-08-04 | $7.72M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $1.93M 10-Q · filed 2021-05-04 | $3.98M derived: sum of 2 quarters · filed 2021-05-04 | $5.61M derived: sum of 3 quarters · filed 2021-05-04 | $7.20M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $3.68M derived: sum of 2 quarters · filed 2021-03-10 | $5.26M derived: sum of 3 quarters · filed 2021-03-10 | $6.79M 10-K · filed 2021-03-10 |
| 2019-09-30 | $1.63M 10-Q · filed 2020-11-03 | $3.22M derived: sum of 2 quarters · filed 2020-11-03 | $4.74M 10-Q · filed 2020-11-03 | $6.13M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | $1.59M 10-Q · filed 2020-08-04 | $3.11M 10-Q · filed 2020-08-04 | $4.50M derived: sum of 3 quarters · filed 2020-08-04 | $5.72M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $1.53M 10-Q · filed 2020-05-05 | $2.91M derived: sum of 2 quarters · filed 2020-05-05 | $4.13M derived: sum of 3 quarters · filed 2020-05-05 | $5.31M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $2.60M derived: sum of 2 quarters · filed 2020-03-11 | $3.79M derived: sum of 3 quarters · filed 2020-03-11 | $4.83M 10-K · filed 2020-03-11 |
| 2018-09-30 | $1.22M 10-Q · filed 2019-11-12 | $2.40M derived: sum of 2 quarters · filed 2019-11-12 | $3.45M 10-Q · filed 2019-11-12 | $4.67M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $1.18M 10-Q · filed 2019-08-07 | $2.23M 10-Q · filed 2019-08-07 | $3.45M derived: sum of 3 quarters · filed 2019-08-07 | $4.78M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $1.05M 10-Q · filed 2019-05-09 | $2.27M derived: sum of 2 quarters · filed 2019-05-09 | $3.59M derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $2.55M derived: sum of 2 quarters · filed 2019-03-14 | $5.11M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $1.33M 10-Q · filed 2018-11-29 | $3.89M 10-Q · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |